Quote:

---

Jamie - AMBS needs revenue - it's just that simple - that's the only thing that will move this security - with 927-Mil. in the float, the churn rate is too high - the Street is also gun shy on taking any positions of significance with a potentially large RS looming. Bobby Farrell and the financial advisors need to address this matter head on

---

I agree that AMBS needs revenue and i'm confident we will hear about that in the coming weeks as Gerald said in his latest blog and i quote:

"we expect to announce additional significant news in the coming weeks regarding LymPro"

So i'm kinda assuming we will hear more news about possible orders for lympro or something like that and get a better picture about revenue.

But we will have to wait and see.